Foren & Soziale Netzwerke zur MIND MEDICINE Aktie

 

MNMD solid move back towards thd $10 range. Key resitstance tomorrow will be the daily lower high from Monday as bulls have regrouped after the rejection from 10.49 and look to want to break through this long term area of resistance once and for all. Hourly uptrend will be my guide as to knowing when this move has topped out. I publish regular technical analysis of the psychedelic sector. Be sure to like and follow to not miss an important update!

MNMD quickly sets the daily higher low and pokes above $10, but then faded for the last three hours of the day. Red flag? Not yet - Here's what I'm looking for into tomorrow to ensure the short term chart remains healthy, which is crucial given where we are on the long term charts at the moment. I publish regular technical analysis of the psychedelic sector. Be sure to like and follow to not miss an important update!

Gap down open starts daily consolidation, bulls are still closing above EMA12 on the daily and I want to see this remain the case. 9.55 is a pretty key short term support, I don't want to see price action lower than this, as that opens up the door to more signification consolidation which is less than ideal after breaking then rejecting hard from a monthly resistance.

Big weekly bull break today without a lot of followthrough. Should we be concerned? I'll take you through the chart history to look at MNMD past bull breaks as well as a spot on the daily timeframe I think is similar to the one we're in now, to see how it plays out. Hourly uptrend remains our guide.

MNMD bulls buy the dip off the daily EMA12 and continue marching towards resistance. Declining volume on the daily timeframe approaching resistance, so hourly uptrend will be our guide for the rest of the week. Hourly chart however does have increasing bull volume which could be an early clue. I publish regular technical analysis of the shrooms sector, be sure to like and follow so you don't miss future updates!

Congrats to the MNMD dip buyers with a 25% bounce from the lows! Here's what I'm watching for to gauge if the bounce topped out, and what we can expect when it eventually does top out. I publish regular technical analysis of the shrooms sector, be sure to like and follow so you don't miss future updates!

Kursziel: 21.5975 €

MNMD had a big gap down open on bad reaction to earnings and a pretty solid bounce before some end of day profit taking. What are we looking at going forward? MNMD S: 7.96 R: 8.83, 9.00

MNMD has started weekly consolidation by 2c right as ATAI and possibly CMPS end their weekly consolidations. Earnings after hours tonight had no real effect on the charts, so here are the levels I'm looking at into tomorrow. Click to watch the free video for more details I provider regular chart analysis of the psychedelics sector. Be sure to Like and Follow, and Subscribe to future updates so you don't miss a post! Support: 8.94, 8.79 Resistance: 9.40, 9.44

NASDAQ:MNMD very healthy sideways consolidation after a 54% surge over the last 4 weeks. 4hr downtrend is our guide and lower lows aren't seeing much followthrough, giving clues there may be a daily bullflag pattern shaping up. EARNINGS THIS WEEK! Support: 9.53, 9.37 Resistance: 9.79, 9.82, 10.09 I post regular analysis of the psychedelics sector, please like and follow to make sure you don't miss my next update!

MNMD bulls are setting up a daily bullflag just below key monthly resistance at 10.44, the break of which would confirm the monthly trend change for the first time in the history of the chart. 10.24 key short term resistance to confirm the bull flag. Support: 9.50, 9.00, 8.79, 8.51, 8.43 Resistance: 10.24, 10.44, 10.47, 11.00, 11.22

Bulls close at high of day, continuing a very strong two week bull move to confirm the weekly uptrend and continue to march towards key Monthly resistance at 10.44. We won't be surprised for daily consolidation when it comes but for now the hourly uptrend is our guide and the daily chart is riding a very fast moving EMA5. Resistances Weekly 200ma, 10.44 Supports 8.43 (short term), 6.40 on daily

MNMD with a very bullish close knocking on the door of double-top weekly resistance at 8.21. Hourly RSI cooled off after hours and bulls want to break this level first thing tomorrow and see clear followthrough for continuation.

MNMD closed July 8th with the most bullish candle since May 19th, finally giving us a convining break of the daily equilibrium, and resulting in a gap up and run this morning with another solid day up over 3%. Today's high rejected from the top of the current high volume node mentioned in my weekend video (7.80), above this there isn't much resistance until the weekly resistance doubletop at 8.21. Hourly RSI is entering into typical pullback areas over the last 6 months so we will be watching the hourly uptrend for clues on pullbacks if we are seeing healthy hourly consolidation or looking for a daily consolidation.

MNMD is looking good on the daily chart for a bull break from it's currently daily equilibrium, but it still remains far from it's weekly and monthly resistance levels that ATAI has already cleared. I do anticipate MNMD to benefit from the GO signal from ATAI but the additional overhead supply may remain an obstacle until we get through it, either through grinding price action or a news catalyst specific to MNMD. Entry: 6.77 Stop loss: 6.27

Kursziel: 17.834 €

Kursziel: 14.7184 €

Kursziel: 50.6935 €

NASDAQ:MNMD Inverse H&S $10.44 BREAKOUT =?$12.25?$15.60 Called this one out a few months ago and how RFK Jr. would send the Psychedelic's Stock flying...He did just that after his inauguration. It could keep flying now with momentum! Not financial advice

Breakout, CHoCH, volume supporting the move, 20.82 target, march Opex expiration. nothing big, I like the setup. why are we running tho?? The confirmation of Robert F. Kennedy Jr. as the head of the U.S. Department of Health and Human Services could have a positive impact on biotech stocks, particularly in the psychedelic space. RFK Jr.'s support for mental health treatments using psychedelics like those being developed by Mind Medicine (MNMD) aligns with a potential shift in policy towards chronic disease prevention and alternative therapies. Analysts believe this could boost biotech companies focused on psychedelics, such as MNMD, which saw a slight uptick in stock following his confirmation.